Urology departments in England and Wales have seen an increase in users admitted for bladder inflammation caused by ketamine use.
Articles on Ketamine
Displaying 1 - 20 of 38 articles
Several religious groups have historically used psychedelics for healing. Now, a growing number are pushing for their use as a way to mystical experiences.
New research gives voice to ketamine addiction sufferers, exposing physical harms, treatment gaps and the urgent need for better education.
After May 1, the drug will cost a tiny fraction of its original price. But it can’t be taken at home.
Ketamine is steadily becoming the drug of choice for many people in the party scene. Here’s how to keep you and your mates safe.
The combination of fentanyl and xylazine that dominates Philadelphia’s illegal dope supply creates agonizing withdrawal symptoms. This presents new challenges for doctors and nurses.
Moving marijuana to a less restrictive category under the Controlled Substances Act poses benefits and potential risks. But no effective medicine is free from risks.
More and more people are seeking medical help for problems related to ketamine use.
Pink cocaine, an unpredictable and dangerous synthetic drug, is rapidly gaining traction on Europe’s party scene.
Cocaine and other illicit drugs have been found to be contain nitazenes, a dangerous class of synthetic opioids.
Nitazenes can be up to 50 times stronger than fentanyl. They’re not yet common in Australia so now is the time to implement policies to reduce their harm and limit their uptake.
What exactly is ketamine and what is its role in the treatment of depression?
Synthetic opioids called nitazenes are ones to watch in 2024.
Perry was being legally prescribed infusions of ketamine.
One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.
The analysis shows that ketamine may start relieving symptoms of PTSD within one day, but it is still unclear how long the effects last and how many injections are needed to maintain benefits.
We still don’t know a lot about how the networks of cells in the brain enable conscious experience.
This latest research provides hope for people whose symptoms are harder to treat.
Approximately 280 million people in the world suffer for depression. Despite this, the disorder remains poorly explained and is often difficult to treat. Ketamine could offer an innovative approach.
What happens when drug testing experts come across a substance they have never seen before?
Top contributors
-
Professor, Mental Health and Addiction, Rural Health Research Institute, Charles Sturt University
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor in Substance Use, Liverpool John Moores University
-
Professor of Cognitive Neuropsychology, University of Hertfordshire
-
Assistant Professor, Department of Chemistry; Department of Biochemistry & Molecular Medicine; Center for Neuroscience, University of California, Davis
-
Professor of History, Shanghai University
-
Psychiatre à la Pitié-Salpêtrière & chercheur à l'Institut du Cerveau - Sorbonne Université AP-HP, Sorbonne Université
-
Enterprise Fellow (Senior Research Fellow/Senior Lecturer), Adelaide University
-
Principal Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University
-
Associate Professor of Psychiatry and Psychology, University of Pittsburgh
-
PhD Candidate, Monash University
-
Associate Professor in Pharmacy Practice and Digital Public Health, Kingston University
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Professor of Neuropharmacology, University of Lancashire